BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$462M |
| 2 |
UnitedHealth
UNH
|
+$441M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$429M |
| 4 |
Analog Devices
ADI
|
+$347M |
| 5 |
Apple
AAPL
|
+$342M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$536M |
| 3 |
Netflix
NFLX
|
+$316M |
| 4 |
PepsiCo
PEP
|
+$293M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$206M |
Sector Composition
| 1 | Technology | 25.21% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Ramaco Resources Class B
METCB
$1.04B
| $3.43K | ﹤0.01% |
483
-460
| -49% | -$3.27K |
|
|
DM
3902
DELISTED
Desktop Metal, Inc.
DM
| $3.41K | ﹤0.01% |
694
-89
| -11% | -$437 |
|
3903
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.3B
| $3.38K | ﹤0.01% |
29
-15
| -34% | -$1.75K |
|
3904
LifeVantage
LFVN
$141M
| $3.37K | ﹤0.01% |
231
| – | – |
|
3905
FiscalNote
NOTE
$65.6M
| $3.37K | ﹤0.01% |
347
-488
| -58% | -$4.74K |
|
|
INZY
3906
DELISTED
Inozyme Pharma
INZY
| $3.33K | ﹤0.01% |
3,662
-3,018
| -45% | -$2.75K |
|
|
BLUE
3907
DELISTED
bluebird bio
BLUE
| $3.31K | ﹤0.01% |
679
-3,866
| -85% | -$18.9K |
|
3908
CVR Partners
UAN
$930M
| $3.31K | ﹤0.01% |
+44
| New | +$3.31K |
|
3909
Black Diamond Therapeutics
BDTX
$185M
| $3.3K | ﹤0.01% |
2,130
-1,983
| -48% | -$3.07K |
|
3910
Werewolf Therapeutics
HOWL
$65.4M
| $3.27K | ﹤0.01% |
3,365
-3,467
| -51% | -$3.37K |
|
|
KG
3911
Kestrel Group, Ltd.
KG
$211M
| $3.19K | ﹤0.01% |
279
-272
| -49% | -$3.11K |
|
3912
Red Robin
RRGB
$121M
| $3.18K | ﹤0.01% |
892
+753
| +542% | +$2.68K |
|
3913
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.35B
| $3.12K | ﹤0.01% |
129
+112
| +659% | +$2.71K |
|
3914
Mural Oncology
MURA
$36M
| $3.01K | ﹤0.01% |
2,386
-41
| -2% | -$52 |
|
3915
Golden Matrix Group
GMGI
$141M
| $3K | ﹤0.01% |
1,521
-2,470
| -62% | -$4.87K |
|
3916
Lunai Bioworks Inc. Common Stock
RENB
$45.9M
| $3K | ﹤0.01% |
5,516
-11,252
| -67% | -$6.11K |
|
3917
Verde Clean Fuels
VGAS
$63.9M
| $2.99K | ﹤0.01% |
891
-266
| -23% | -$891 |
|
3918
Nautilus Biotechnolgy
NAUT
$91M
| $2.98K | ﹤0.01% |
3,457
-3,793
| -52% | -$3.27K |
|
3919
Corvus Pharmaceuticals
CRVS
$434M
| $2.97K | ﹤0.01% |
933
+72
| +8% | +$229 |
|
3920
Actinium Pharmaceuticals
ATNM
$50.8M
| $2.95K | ﹤0.01% |
1,833
-3,911
| -68% | -$6.3K |
|
3921
Vanguard International High Dividend Yield ETF
VYMI
$12B
| $2.95K | ﹤0.01% |
+40
| New | +$2.95K |
|
|
SOGP
3922
Sound Group
SOGP
$103M
| $2.95K | ﹤0.01% |
1,340
+400
| +43% | +$880 |
|
|
TBNK
3923
DELISTED
Territorial Bancorp Inc.
TBNK
| $2.91K | ﹤0.01% |
347
| – | – |
|
|
AKYA
3924
DELISTED
Akoya BioSciences
AKYA
| $2.9K | ﹤0.01% |
2,084
-2,179
| -51% | -$3.03K |
|
3925
Ispire Technology
ISPR
$187M
| $2.89K | ﹤0.01% |
1,059
-859
| -45% | -$2.35K |
|